GoodRx $32 Million Privacy Settlement — No Proof Needed, Claim by Dec. 29, 2026
PublishedOctober 14, 2026
People in the U.S. who used any GoodRx website, app or service, including GoodRx Gold, HeyDoctor and GoodRx Care, before April 20, 2024 may qualify to claim a cash payment from the $32 million GoodRx privacy class action settlement. Claims close December 29, 2026, and the online claim form asks for no receipts, documents or notice ID.
Claims are open in the $32 million settlement between GoodRx, the ad-technology company Criteo and
people who used GoodRx before April 20, 2024. The deadline is December 29, 2026: online claims are due
by 11:59 p.m. Eastern Time that day, and mailed claim forms must be postmarked by that date. The court
granted preliminary approval on September 8, 2026, and the final approval hearing is set for
February 11, 2027. No final approval order had been entered and no payment date had been announced as
of October 14, 2026.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
StatusClaims Open
Claim DeadlineDecember 29, 202611:59 p.m. ET online · postmarked by this date if mailed
Estimated PayoutEqual share of the net fund$32M fund before fees and costs · amount depends on the number of valid claims · not yet announced
Proof RequiredNoNo receipts, documents or notice ID on the online form · claimants attest to U.S. residence and GoodRx use before April 20, 2024
What Changed Recently?
On September 8, 2026, U.S. District Judge Araceli Martínez-Olguín of the Northern District of
California preliminarily approved the settlement in Doe, et al. v. GoodRx Holdings, Inc., et al.,
No. 4:23-cv-00501-AMO. The order provisionally certified a nationwide settlement class, appointed
A.B. Data as the settlement administrator, approved the notice plan and set every deadline that now
applies. The settlement website is live, and its File a Claim page is accepting claims.
The case centers on allegations that GoodRx passed users’ health and prescription information to
advertising companies through tracking code on its website and app. GoodRx and Criteo deny the
allegations and deny violating any law; they agreed to settle to avoid the cost and uncertainty of
further litigation, and the settlement is not a finding of wrongdoing. When the deal was first filed
in June 2026, before the court had acted on it, the claim window had not opened and no deadlines had
been set; OCA’s earlier report on that stage is
GoodRx agrees to $32 million privacy settlement.
Who Qualifies?
The settlement class is all natural persons in the United States who used any website, app or service
made available by or through GoodRx at any time before April 20, 2024. That reaches the main GoodRx
website and app as well as GoodRx Gold, HeyDoctor and GoodRx Care. The class is not limited to people
who received an email notice, and it is not limited by state.
Excluded from the class are GoodRx and Criteo and their affiliates, parents, subsidiaries, officers
and directors; Meta and Google; anyone who opts out; and the judges presiding over the case and their
clerks.
Meta Platforms and Google are defendants in the same lawsuit, but they are not part of this
settlement. The plaintiffs’ claims against those two companies continue separately, so this deal
pays only for the claims against GoodRx and Criteo.
How Much Can You Get?
GoodRx and Criteo agreed to pay $32,000,000 into a non-reversionary settlement fund, meaning no
leftover money goes back to either company. Before anything is divided among claimants, the fund
pays notice and administration costs, taxes, fund account costs, any attorneys’ fees and expenses the
court awards, service awards for the class representatives, and any other costs the court approves.
What remains is the net settlement fund.
Every class member who files a valid, timely claim receives the same amount: the net fund divided by
the number of valid claims. Neither the notice nor the settlement website gives a per-person estimate,
because the figure depends entirely on how many people file. Class Counsel, Lowey Dannenberg, P.C.
and Bursor & Fisher, P.A., have said they will ask for attorneys’ fees of no more than one-third of the
fund (about $10.67 million) plus up to $125,000 in litigation expenses, and the class representatives
may request service awards of up to $2,000 each. The court decides those requests at or after the
final approval hearing.
Claimants choose how to be paid on the claim form: PayPal, Venmo, Zelle, a virtual prepaid card or a
physical check mailed to the address on the form. If the electronic payment details are not enough to
send the money, the administrator mails a check instead. Checks become void if they are not cashed
within 60 days of issue.
What Proof or Notice ID Is Required?
None. The online claim form, reached through the File a Claim button on the settlement website, asks
for the claimant’s first and last name, a street address, city, state, ZIP code, email
address and phone number, a payment choice, and an electronic signature. There is no field for a
Claimant ID code or Confirmation code and no place to upload documents. The emailed summary notice
does carry both codes, but the online form does not ask for them, so a class member who never got an
email can still file.
What the form does require is an attestation: the claimant checks a box stating that they resided in
the United States and used a website, app or service made available by or through GoodRx before
April 20, 2024, and certifies that the information on the form is true, correct and complete. Filing
is open to class members only. The administrator reviews each claim for validity, timeliness and
completeness and has the right to audit claims for fraud; a claimant whose form is found incomplete
gets written notice and 20 days to fix it, or the claim is treated as invalid.
What Is the Deadline?
Claims are due December 29, 2026. An online claim must be submitted by 11:59 p.m. Eastern Time that
day; a paper claim form must be postmarked no later than December 29, 2026.
The same date applies to the two other options a class member has. A request to be excluded from the
settlement must be mailed and postmarked by December 29, 2026; it cannot be made by phone or email, and
it has to include the case name and number, the person’s full name, address, phone number and email,
the claimant ID code and other information from the summary notice, an original signature, and a
clear statement of intent to be excluded. Someone who opts out receives no payment and keeps the
right to pursue their own claims against GoodRx and Criteo. A written objection must be filed with
the court by December 29, 2026, and only class members who stay in the settlement may object.
How Do You Take Action?
Claims are filed on the official settlement website’s
claim form page,
which is also linked from the File a Claim button on the
GoodRx Privacy Settlement website.
The form takes contact details, a payment method, the attestation checkbox and a typed signature,
and after an online submission a printable Confirmation of Claim Receipt appears on screen. A
printable claim form is also posted on the settlement website for anyone who prefers to mail one, and
it lists the administrator’s mailing address. The claim form, notice and court orders are collected
on the site’s
court documents page.
Questions about a specific claim go to A.B. Data through the contact options listed on the
settlement website. The notice asks class members not to contact the court or the clerk’s office about
the settlement.
What Happens Next?
Class Counsel’s motions for final approval, attorneys’ fees and expenses, and service awards are due
November 24, 2026, and the notice says they will be posted on the settlement website once filed.
After the December 29 deadlines pass, the court’s schedule gives the parties until January 28, 2027 to
complete discovery about any objections and until February 2, 2027 to respond to them.
The final approval hearing is scheduled for February 11, 2027, at 11:00 a.m. before Judge
Martínez-Olguín in Courtroom 5 of the federal courthouse in Oakland. The notice warns that the date or
time may change without further notice and that the hearing could be held remotely. Final approval is
not guaranteed, and any approval can be appealed.
Under the settlement agreement, the administrator sends payments within 45 days after the Effective
Date, which comes only after final approval and the end of any appeals. The notice cautions that an
appeal can take a year or more to resolve. No payment date had been announced as of October 14, 2026.
What the Lawsuit Alleges
GoodRx runs a prescription-coupon and telehealth business. The plaintiffs allege that from at least
2017 to 2020, GoodRx disclosed users’ personal and health information, including information about
their prescriptions and health conditions, email addresses and phone numbers, to advertising and
analytics companies, among them Criteo, Meta and Google. According to the complaint, the data moved
through JavaScript pixels, software development kits, cookies and APIs built into GoodRx’s website and
apps, and the receiving companies then used the information for their own purposes.
The plaintiffs assert claims for intrusion upon seclusion, unjust enrichment, negligence and
negligence per se, along with alleged violations of the California Confidentiality of Medical
Information Act, the California Invasion of Privacy Act, the California Consumers Legal Remedies Act,
California’s Unfair Competition Law, New York’s General Business Law and the Illinois Consumer Fraud
and Deceptive Business Practices Act. GoodRx and Criteo dispute the allegations, deny violating any
law and maintain that they have meritorious defenses. The court has not ruled for either side on the
merits.
The private suits followed a Federal Trade Commission action filed against GoodRx on February 1, 2023,
in which the FTC alleged that GoodRx violated the FTC Act and the agency’s Health Breach Notification
Rule by disclosing users’ personal information and medication and health-condition details to third
parties. The first class complaints were filed the next day and were consolidated into this case in
May 2023. GoodRx reached a settlement with the plaintiffs after mediation in 2024, Criteo followed in
2025, and the combined amended agreement was signed November 19, 2025. A March 24, 2026 addendum
narrowed the release so that it covers claims tied to the alleged data disclosure through tracking
technologies on GoodRx’s website, app and related services before April 20, 2024, or claims based on
the complaint’s factual allegations.
Class members who stay in the settlement give up the right to sue GoodRx, Criteo and their related
parties over those released claims, whether or not they file a claim. The release does not reach Meta
or Google.
Sources and Verification
This page is based on the court-approved documents and the live settlement website:
The long-form Notice of Proposed Class Action Settlement, embedded below.
The Order Preliminarily Approving the Proposed Class Action Settlement (ECF No. 379, entered September 8, 2026), the Amended Class Action Settlement Agreement and Release dated November 19, 2025, the March 24, 2026 addendum, the summary notice and the claim form, all posted on the settlement website’s court documents page.
The case now carries the Oakland division number 4:23-cv-00501-AMO; earlier filings, including the
settlement agreement and addendum, bear the San Francisco designation 3:23-cv-00501-AMO for the same
case.
OpenClassActions.com is a consumer news and information site, not a law firm. This article is general
information about the GoodRx privacy settlement. It is not legal advice, and reading it does not create
an attorney-client relationship.
Questions
Does the GoodRx settlement cover Meta and Google?
The $32 million settlement resolves the claims against GoodRx Holdings, Inc. and Criteo Corp. only. Meta and Google are also defendants in the same case, but the plaintiffs’ claims against them are not part of this deal and are still being litigated. Meta and Google are also excluded from the settlement class, and the release covers GoodRx, Criteo and their related parties.
Why does the GoodRx claim form not ask for the code in the notice email?
The emailed summary notice prints a Claimant ID code and a Confirmation code, but the online claim form that the settlement website’s File a Claim button opens has no field for either. It asks for name, street address, email, phone number, a payment choice, an attestation about U.S. residence and GoodRx use before April 20, 2024, and an electronic signature. The Claimant ID code does matter for a different step: a written request to be excluded from the settlement has to include it.
Can one person file more than one GoodRx claim?
The claim form limits each settlement class member to one claim for one pro rata cash payment, regardless of how many notices that person receives. Someone completing the form on behalf of another person has to attach documentation showing their authority to act for that claimant.
How is the GoodRx class action related to the FTC case?
According to the settlement notice, the Federal Trade Commission filed an action against GoodRx on February 1, 2023, alleging that it violated the FTC Act and the FTC’s Health Breach Notification Rule by disclosing users’ personal information and details about their medications and health conditions to third parties. Private class actions began the next day and were consolidated in May 2023. The FTC matter is a separate government action; this $32 million settlement resolves only the private class claims against GoodRx and Criteo.
What happens to GoodRx settlement money that is not cashed?
Settlement checks become void if they are not cashed within 60 days of issue. Under the settlement agreement, money left over from uncashed checks is redistributed pro rata to claimants who cashed their checks or chose an electronic payment, as long as each redistributed share would be at least $5. Any money still left more than 180 days after payments go out goes to the Center for Internet and Society at Stanford Law School. None of it returns to GoodRx or Criteo.
Could the GoodRx settlement still fall apart?
Final approval is not guaranteed. The court has granted only preliminary approval, and final approval will be considered at the February 11, 2027 hearing. Separately, GoodRx and Criteo have the right, but not the obligation, to terminate the settlement if the number of class members who opt out exceeds a threshold set in a confidential side agreement. If the settlement is not approved or is terminated, no settlement payments are made and the case continues against GoodRx and Criteo.
Official Settlement Notice
For more class actions keep scrolling below.
Settlement Amount
$32,000,000
Case Title
Doe, et al. v. GoodRx Holdings, Inc., et al.
Case Number
4:23-cv-00501-AMO
Court
U.S. District Court, Northern District of California (Oakland)
Final Approval Hearing
February 11, 2027 at 11:00 AM Judge Araceli Martínez-Olguín · Courtroom 5 · date may change; may be held remotely